KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Raw Materials (2016 - 2025)

CareDx's Raw Materials history spans 13 years, with the latest figure at $13.2 million for Q4 2025.

  • For Q4 2025, Raw Materials rose 20.84% year-over-year to $13.2 million; the TTM value through Dec 2025 reached $13.2 million, up 20.84%, while the annual FY2025 figure was $13.2 million, 20.84% up from the prior year.
  • Raw Materials for Q4 2025 was $13.2 million at CareDx, down from $13.7 million in the prior quarter.
  • Across five years, Raw Materials topped out at $13.9 million in Q2 2025 and bottomed at $8.1 million in Q1 2021.
  • The 5-year median for Raw Materials is $10.8 million (2023), against an average of $11.2 million.
  • The largest annual shift saw Raw Materials surged 364.53% in 2021 before it dropped 14.41% in 2023.
  • A 5-year view of Raw Materials shows it stood at $10.4 million in 2021, then grew by 14.52% to $12.0 million in 2022, then decreased by 11.22% to $10.6 million in 2023, then grew by 2.53% to $10.9 million in 2024, then rose by 20.84% to $13.2 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Raw Materials are $13.2 million (Q4 2025), $13.7 million (Q3 2025), and $13.9 million (Q2 2025).